BCDG

David Riese, Associate Professor of Medicinal Chemistry and Molecular Pharmacology
Dr. Riese’s research focuses on the effects of increased and decreased ErbB4 signaling in breast tumor cell lines.  Dr. Riese’s group is investigating the effects of changes in ErbB receptor expression on chemotherapy sensitivity and resistance. This group is also developing novel ligand-based antagonists for ErbB receptors and evaluating the anti-tumor activities of these agents.

For more information on Dr. Riese, visit his department website here.